Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1-Dodecyl-1H-benzo[d]imidazol-2(3H)-one.

ABSTRACT: In the title compound, C(19)H(30)N(2)O, the fused ring system is essentially planar, the maximum deviation from the mean plane being 0.013?(2)?Å for the N atom bearing the dodecyl chain. The 1-dodecyl group is almost perpendicular to the 1H-benzo[d]imidazol-2(3H)-one plane as indicated by the dihedral angle of 82.9?(2)°between planes through the fused ring system and the first three C atoms of the chain. The C-C-C-C torsion angles (about ±179°) of the dodecyl group indicate an anti-periplanar conformation. In the crystal, inversion dimers are formed by pairs of N-H?O hydrogen bonds.

SUBMITTER: Belaziz D

PROVIDER: S-EPMC3515176 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1-Dodecyl-1H-benzo[d]imidazol-2(3H)-one.

Belaziz Dounia D Kandri Rodi Youssef Y Ouazzani Chahdi Fouad F Essassi El Mokhtar el M Saadi Mohamed M El Ammari Lahcen L

Acta crystallographica. Section E, Structure reports online 20121006 Pt 11

In the title compound, C(19)H(30)N(2)O, the fused ring system is essentially planar, the maximum deviation from the mean plane being 0.013 (2) Å for the N atom bearing the dodecyl chain. The 1-dodecyl group is almost perpendicular to the 1H-benzo[d]imidazol-2(3H)-one plane as indicated by the dihedral angle of 82.9 (2)°between planes through the fused ring system and the first three C atoms of the chain. The C-C-C-C torsion angles (about ±179°) of the dodecyl group indicate an anti-periplanar co ...[more]

PMID: 23284403

Similar Datasets

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one Derivatives.

Project description:A series of novel 5-hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one derivatives bearing natural product substructures has been successfully synthesized and their antitumor activity studied. These newly synthesized derivatives were characterized by ¹H-NMR, (13)C-NMR and high resolution mass spectral data, then screened as antitumor agents against the A549, HCC1937, and MDA-MB-468 human tumor cell lines using MTT cell proliferation assays. The results show that some of these compounds can effectively inhibit the growth of these cancerous cells, with compound 5b being the best one (IC50 = 2.6 ?M). Flow cytometry data revealed that compound 5b induced apoptosis of HCC1937 cells with increased solution concentration. The structure and activity relationships (SAR) of these compounds is summarized.

| S-EPMC6273811 | biostudies-other

1,3-Bis(2-methyl-prop-2-eno-yl)-1H-benz-imidazol-2(3H)-one.

Project description:The mol-ecules of the title compound, C15H14N2O3, possesses crystallographically imposed twofold rotational symmetry, so the asymmetric unit contains one half-mol-ecule. The fused-ring system deviates significantly from planarity; the planes of the five- and six-membered rings are twisted with respect to each other by 3.0 (1)°. In the crystal, weak C-H⋯O hydrogen bonds link mol-ecules related by translation in [010] into chains.

| S-EPMC3684908 | biostudies-literature

2-(1H-Imidazol-1-yl)-3-isopropyl-1-benzothieno[3,2-d]pyrimidin-4(3H)-one.

Project description:In the title compound, C(16)H(14)N(4)OS, the three fused rings of the benzothieno[3,2-d]pyrimidinone unit are essentially coplanar, the maximum deviation from the mean plane being 0.067 (3) Å. The dihedral angle between the mean plane of the fused rings and the imidazole ring is 72.00 (3)°. Offset π-π stacking inter-actions involving the fused rings are effective in the stabilization of the crystal structure. The centroid-centroid distances between the thienophene and benzene rings, and between the pyrimidine and benzene rings are 3.67 (1) and 3.93 (1) Å, respectively. There are two intramolecular C-H⋯O interactions.

| S-EPMC2915283 | biostudies-literature

3,3,6-Tribromo-1-methyl-1H-2,1-benzo-thia-zin-4(3H)-one 2,2-dioxide.

Project description:In the title compound, C(9)H(6)Br(3)NO(3)S, a halogenated benzothia-zine derivative, the thia-zine ring adopts a sofa conformation. The crystal studied was a racemic twin with a contribution of 72?(1)% of the major domain.

| S-EPMC3011660 | biostudies-literature

Dibromidobis[1-(2-bromo-benz-yl)-3-(pyrimidin-2-yl)-1H-imidazol-2(3H)-one]copper(II).

Project description:In the title complex, [CuBr(2)(C(14)H(11)BrN(4)O)(2)], the Cu(II) ion is located on an inversion centre and is coordinated by two ketonic O atoms, two N atoms and two Br atoms, forming a distorted octahedral coordination environment. The two carbonyl groups are trans positioned with C=O bond lengths of 1.256?(5)?Å, in agreement with a classical carbonyl bond. The Cu-O bond length is 2.011?(3)?Å. The two bromo-benzyl rings are approximately parallel to one another, forming a dihedral angle of 70.1?(4)° with the coordination plane.

| S-EPMC3379115 | biostudies-literature

Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase.

Project description:A series of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones were synthesized and evaluated for their ability to inhibit human and porcine forms of D-amino acid oxidase (DAAO). Inhibitory potency is largely dependent on the size and position of substituents on the benzene ring with IC(50) values of the compounds ranging from 70 nM to greater than 100 µM. Structure-activity relationships of this new class of DAAO inhibitors will be presented in detail along with comparisons to previously published SAR data from other classes of DAAO inhibitors. Some of these compounds were given to mice orally together with D-serine to assess their effects on plasma D-serine pharmacokinetics.

| S-EPMC3519437 | biostudies-literature

(±)-3-(5-Amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-benzo-furan-1(3H)-one.

Project description:In the title compound, C18H15N3O2, the benzo-furan ring system is essentially planar, the rings making a dihedral angle of 0.57 (9)°. The phenyl, furan and benzene rings subtend dihedral angles of 47.07 (10), 85.76 (7) and 86.04 (7)°, respectively, with the pyrazole ring. In the crystal, mol-ecules are linked by weak N-H⋯N, N-H⋯O and C-H⋯O inter-actions, generating edge-fused R 4 (4)(20), and R 1 (2)(7) rings linked into sheets which are parallel to (010).

| S-EPMC3770437 | biostudies-literature

1-Octyl-1H-benzimidazol-2(3H)-one.

Project description:In the title compound, C(15)H(22)N(2)O, the octyl group adopts an all-trans conformation. In the crystal, mol-ecules form centrosymmetric dimers with an R(2) (2)(8) graph-set motif, linked by pairs of N-H?O hydrogen bonds. In addition, C-H?O contacts are observed.

| S-EPMC3344429 | biostudies-literature

1-Benzyl-1H-benzimidazol-2(3H)-one.

Project description:The fused five- and six-membered rings in the title compound, C(14)H(12)N(2)O, are essentially planar, the largest deviation from the mean plane being 0.023?(2)?Å. The dihedral angle between the benzimidazole mean plane and the phenyl ring is 68.50?(6)°. In the crystal, each mol-ecule is linked to its symmetry equivalent created by a crystallographic inversion center by pairs of N-H?O hydrogen bonds, forming inversion dimers.

| S-EPMC3151763 | biostudies-literature

1-Nonyl-1H-benzimidazol-2(3H)-one.

Project description:The crystal structure of the title compound, C(16)H(24)N(2)O, is built up from two fused six- and five-membered rings linked to C(9)H(19) chains. The fused-ring system is essentially planar, the largest deviation from the mean plane being 0.009 (2) Å. The chain is nearly perpendicular to this plane [dihedral angle = 80.27 (17)°]. In the crystal, inter-molecular N-H⋯O hydrogen bonds form dimers with an R(2) (2)(8) graph-set motif. These dimers are further connected through C-H⋯O hydrogen bonds, building sheets parallel to (100).

| S-EPMC3051596 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data